Earnings Labs

Oaktree Specialty Lending Corporation (OCSL)

Q3 2018 Earnings Call· Wed, Aug 8, 2018

$12.60

-0.28%

Key Takeaways · AI generated
AI summary not yet generated for this transcript. Generation in progress for older transcripts; check back soon, or browse the full transcript below.

Same-Day

+1.01%

1 Week

+1.42%

1 Month

+1.42%

vs S&P

+0.50%

Transcript

Operator

Operator

Welcome and thank you for joining Oaktree Specialty Lending Corporation’s Third Quarter 2018 Conference Call. Today’s conference call is being recorded. At this time, all participants are in a listen-only mode. [Operator Instructions] Now, I would like to introduce Michael Mosticchio of Investor Relations, who will host today’s conference call. Mr. Mosticchio, you may begin.

Michael Mosticchio

Analyst

Thank you, operator, and welcome to Oaktree Specialty Lending Corporation’s third quarter 2018 conference call. Both our earnings release, which we issued this morning and the accompanying slide presentation, can be accessed on the Investors section of our website at oaktreespecialtylending.com. Our speakers today are Oaktree Specialty Lending’s Chief Executive Officer and Chief Investment Officer, Edgar Lee; Chief Financial Officer and Treasurer, Mel Carlisle; and Chief Operating Officer, Matt Pendo. We will be happy to take your questions following their prepared remarks. Before we begin, I want to remind you that comments today will include forward-looking statements reflecting our current views with respect to, among other things, our future operating results and financial performance. Our actual results could differ materially from those implied or expressed in the forward-looking statements. Please refer to our SEC filings for a discussion of these factors. We undertake no duty to update or revise any forward-looking statements post after today’s call. I’d also like to remind you that nothing in this call constitutes an offer to sell or solicitation of an offer to purchase any interest in any Oaktree fund. Investors and others should note that Oaktree Specialty Lending uses the Investors section of its corporate website to announce material information. Accordingly, the Company encourages investors, the media and others to visit our corporate website to obtain investor related materials. With that, I would now like to turn the call over to our Chief Executive Officer, Edgar Lee.

Edgar Lee

Analyst · JMP Securities

Thank you, Mike, and welcome everyone to our third quarter 2018 earnings conference call. We appreciate your continued interest in OCSL and your participation in today’s call. Our primary focus since Oaktree acquisition has been to stabilize and reposition our imperative portfolio by editing non-core assets, while expanding the amount of core assets in the portfolio. We continue to closely monitor the direct lending landscape for new investment opportunities that align with Oaktree’s underlying philosophy of controlling downside risks. The ultimate goal of these repositioning efforts is to improve ROE for our shareholders. We have made significant progress and repositioning our portfolio and stabilizing NAV since we began managing OCSL last October. Over a period of just nine months, we have refinancing and repayments of almost $1 billion of assets in our portfolio. During that same time, we've reduced our non-core asset exposure by 60% or $536 million. At the end of the third quarter, only 26% of the portfolio at fair value remained in non-core investments, many of which have been demonstrating stable operating trends. It is especially noteworthy that $536 million of the non-core assets we exited were spread across 55 individual positions, many of which were illiquid and challenged. In addition, we exited the vast majority of these investments either at PAR value or above their previous fair value marks, demonstrating our ability to maximize value for our investors. I am very proud of our team's hard work and successfully monetizing these assets. Over the same period, we also doubled the amount of core investments that we hold as we added nearly $786 million of new investments across 52 companies to the portfolio. $380 million of these new assets were added in the third quarter. As of June 30th, core investments totaled over $1 billion in market…

Mel Carlisle

Analyst · JMP Securities

Thank you, Edgar. We had a good quarter, and we are pleased with our improving financial performance. Net investment income in third quarter was $14.4 million or $0.10 per basic and diluted share. This was down slightly from $15.3 million or $0.11 per share last quarter. Mainly due to reduce investment income and partially offset by lower interest expense. Total investment income for the quarter was $31.8 million, down from $34.8 million in the March quarter. This was primarily due to decreases in PIK interest and both fee and dividend income. The decrease in dividend income was partially due to the Kemper joint venture, not paying a dividend this quarter. I will discuss our Kemper joint venture and more details shortly. Cash interest income was flat for the quarter despite a slightly larger portfolio. This was mainly due to a quarter-over-quarter decrease of $1 million related to an investment placed on non-accrual status and a $400,000 decline in original issue discount income due to zero loan repayments during the quarter. In addition, a significant number of modest conditions occurred at the beginning of the quarter, we reinvested those proceeds towards the end of the quarter creating a drag on interest income. These items are partially offset by higher rates following to the LIBOR reset in March. Interest expense declined approximately $250,000 in the third quarter mainly driven by lower average borrowing and partially offset by higher average interest rates. Net operating expenses for the quarter were $9.1 million, down from $10.9 million from last quarter reflecting lower professional fees, G&A expenses and incentive fees. Now turning to credit quality. At June 30th, 4.6% of our debt investments at fair value were at non-accrual status. One investment currently valued at $38 million was moved to non-accrual status following a payment default…

Matt Pendo

Analyst · Wells Fargo. Please go ahead

Thank you, Mel. Since the end of the last fiscal year, we have successfully rotated out of over $60 million of non-interest generating investments including equity, limited partnership interest and non-accrual loans. This amount includes $14 million from the sale of the majority of our limited partnership interest in the third quarter. Importantly, these were sold at a slight premium to the net asset values. As of June 30th, we had a $135 million remaining in non-interest generating investments spread across 42 companies and four LP positions. We continue to benefit from rising interest rates in the third quarter given that our portfolio consist primarily of floating rate assets, with a monthly fix rate liability structure. We expect to see more benefits, if there are additional rate increases this year. As Mel highlighted, we continue to optimize our Kemper JV. During the quarter, we grew the joint venture to $357 million of total assets and lower borrowing costs by 40 basis points. As we grow the joint venture, we expect it will be further accretive to ROE. Finally, during the third quarter, we have responded to market conditions by temporarily increasing our exposure to broadly syndicated loans to $57 million, as of June 30th. We are investing in more liquid loans in order to earn spread income until we can deploy capital into higher yielding proprietary investments that we want to hold over the long-term. We felt this was an appropriate type of move and not a change in our strategy. Taking a prudent and selective approach to investing is paramount in the current environment. As such, we are confident that by leveraging the Oaktree platform, we’ll be successful in originating and structuring attractive transactions that ensure downside protection, a hallmark of Oaktree’s investment approach and deliver higher yields without assuming additional risk. Now turning to our dividend, as you saw in our press release, we declared a $0.095 dividend today. This is unchanged from last quarter and represents approximately 93% of the net investment income earned in the third quarter. In conclusion, we are pleased with the significant progress we have made in repositioning the OCSL portfolio and stabilizing NAV. Our team is executing well against all of our key initiatives and we are making strong progress against our long-term goals, delivering high single digit ROE and a consistent dividend. Thank you for your time and attention today, we look forward to keeping you updated on our progress. And with that operator, please open up the lines for questions.

Operator

Operator

We now begin the question-and-answer session. [Operator Instructions] Our first question will come from Chris York of JMP Securities.

Chris York

Analyst · JMP Securities

Maybe Edger, could you provide us an update on your thoughts for pursuing leverage above your current target of 0.85x, give me a progress of exiting non-core investments? And then the portfolio growth this quarter, which Matt did say included some DSLs and then also expand leverage?

Edgar Lee

Analyst · JMP Securities

Thanks for the question, Chris, and good morning. Right now, we don't have any intensions to adjust leverage at this time, but together with the board we continue to evaluate our leverage position and where we may take that overtime. Right now, we're comfortable with the current leverage position and we feel that we have ample capacity on our existing facilities as we’ve only levered 0.73x right now as well as we have capacity in our Kemper joint venture. Having said that, we're considering number of different factors and weighing those as we consider what to do with respect to leverage long-term and those also include our cost to capital and the impact on our credit ratings.

Chris York

Analyst · JMP Securities

Alright thanks for the update. See weighted average yield, I'm looking to try to get that number for your exits. We've got 8.1 per yield on new investments and I'm conversely trying to find the number. I probably looking pull it off, but maybe Mel, do you have that for us?

Mel Carlisle

Analyst · JMP Securities

8%. The yield on the exits was 10%, sorry.

Chris York

Analyst · JMP Securities

Yes, that makes some sense. And then I'm aware that Allan Media in the market with Deutsche and Jefferies seeking new term financing. So do you expect to be refinanced of your term loan this quarter?

Edgar Lee

Analyst · JMP Securities

The transaction with that has been contemplated by Allan Media in the marketplace today hasn't closed yet. Should they raise the capital that they’re seeking to raise, we'd anticipate being refinanced out of that loan.

Chris York

Analyst · JMP Securities

And then the mark at quarter-end in my view doesn't imply any prepayment penalties or premiums associated with that. Is that fair?

Edgar Lee

Analyst · JMP Securities

That's what I would say, we don't typically comment on the structures of our loans due to certain confidentiality provisions. But as a general matter, I would say that all of our proprietary loans typically have a meaningful prepayment premium as well as a typically a one year non-call period. In our standard loans, anyone who refinances us one year, non-call period would typically have to pay us a make whole premium as well.

Chris York

Analyst · JMP Securities

And then the lastly on the Kemper JV, you took that down you've talked a little bit about the performance and views longer term there. But do you see recovery valuing your equity as spread income potentially returns?

Mel Carlisle

Analyst · JMP Securities

Yes. We've taken steps to optimize our Kemper JV and adding $91 million during the quarter. We took over the vehicle was under invested. That’s why you saw the equity being taken down. But overtime as we ramp the vehicle and optimize that we expect that it will be covered.

Operator

Operator

The next question comes from Christopher Testa of National Securities.

Christopher Testa

Analyst · National Securities

So just curious, you guys noted that you have 104 million of underperforming non-core and only 67 million of that are non- accrual. So, the delta between those two, I’m just curious, if how many portfolio companies comprised of that difference? And is that confined to a certain problematic sector in the inherited portfolio like healthcare? or is it just more spread out?

Edgar Lee

Analyst · National Securities

It’s not confined to a specific sector. It is more broad-based on company specific. So it’s less about the specific industry of these investments and much more about the specific -- company specific issues there.

Christopher Testa

Analyst · National Securities

And, Edgar, how many companies comprised of difference that are not yet on mom-accrual?

Edgar Lee

Analyst · National Securities

There are -- there’s one company right now, that’s on non-accrual.

Christopher Testa

Analyst · National Securities

No, no. I mean between -- so you have 104 million underperforming and then they’re 67 million on on-accrual. So, the difference between the 104 and 67 like how many companies are within that underperforming but not yet on non-accrual status bucket?

Edgar Lee

Analyst · National Securities

It’s one company?

Christopher Testa

Analyst · National Securities

That still one. Okay. And I know, you guys had previously talked about Fifth Street’s healthcare book had a lot of reimbursement risk and other issues. Just wondering, if there’s been any noticeable difference in the trend for any of these whether positive or negative over the last quarter?

Edgar Lee

Analyst · National Securities

I would say it’s a mixture. When we -- as a general matter, the legacy Fifth Street portfolio, many of those companies we’ve already exited. Those that were in healthcare did have some challenges with reimbursement risks. We did manage to move a number of those positions out of a portfolio already. As we look at this bucket of underperforming companies in healthcare for example. I would say generally the healthcare companies have had pretty balanced performance with at least one of them experience relatively positive trends more recently.

Christopher Testa

Analyst · National Securities

And looking at the non-accruals, I know that Garrison Film resolution was added and that’s also a position in the JV previously Ameritox and Metamorph more were on the balance sheet and in the JV. Is your policy going forward to have the Kemper JV have completely, totally different investment mandates? So should we expect there to not be co-investment between that and the on balance sheet portfolio? Or will you opportunistically put them in both buckets as well?

Edgar Lee

Analyst · National Securities

I would expect that overtime, the Kemper JV portfolio will start to look slightly different than the overall portfolio overtime, but there will continue to be some level of overlap between the JV and the main BDC.

Operator

Operator

[Operator instructions] Our next question will come from Ryan Lynch of KBW.

Ryan Lynch

Analyst · KBW

One question on the leverage, you mentioned you guys read about 0.73x debt-to-equity today, But if I look at your balance sheet, you guys had about a $167 million payables on several transactions on the balance sheet, which I am assuming or have close post quarter and if you add those to your current leverage, as you guys at be at 0.92x debt-to-equity, so that’s outside of your normal kind of targeted debt-to-equity range. So can you just talk about where you guys expecting some big prepayments, repayments early in the third quarter to offset those? Or did you guys sell some non-core DSL loans or just kind how that’s working?

Edgar Lee

Analyst · KBW

Good morning and thanks for the question. So one item to keep in mind is that we did have cash on the balance sheet as well, as there was just timing around proceeds coming in and capital going out, and so we would imagine that you’d see our leverage within the range, target range that we’ve been -- we have mentioned in the past. Again it’s just really a timing items here, as we don’t anticipate moving materially out of target ranges in the quarter. Since the beginning of the third quarter, we have had some monetization events occur, but we anticipate that will continue to occur throughout the quarter and we have been deploying capital as well during the quarter. So, you can imagine that just basically for your modeling purposes expect that leverage will stay in line with our historical levels.

Ryan Lynch

Analyst · KBW

Okay, that’s good to know. And then -- and you guys don’t have done a really great job of monetizing a lot of non-core assets even in the most recent quarter you guys had substantial decrease. You still have about $350 million of non-core of investments. I would think that monetizing, I guess early on in the monetization process of reducing non-core investment. I think I would assume it would like be easier to monetize some of those investments maybe pick of some of the lower hanging fruit as we start to get down to the bottom hand of these non-core investments. Should we expect a lengthy period from now to reducing those $350 million of remaining of investments?

Edgar Lee

Analyst · KBW

I wouldn’t necessarily characterize it that way. I think people looked historically at assets that we have monetized a number of those assets were challenge as well. So, I don’t know if it’s really a fair characterization to assume that the balance of these investments are the most challenged investments, that we originally identified in the non-core buckets. But rather it’s been relatively spread out. As we go forward, if we were to breakdown the non-core bucket, I think one way to look at it is about half of those investments are in assets that are either liquid investments where we do have an active bid in the marketplace where we can sell those assets, and I’ll come back to the reasons why we haven’t necessarily move those right away. Two, they’re -- that also includes assets that we are actively selling, right now, where we may have restructured or own the Company today, and we are actively marketing and selling those companies. Or three, companies where we are actively trying to sell the dead investments; and lastly, investments where we have received notice that the Company are and the borrowers to refinance our loans, there is always uncertainty in those later three buckets around timing. And when that can occur, but I would say that for about half of that bucket or little over half of that bucket, there is active activities going on to further reduce our non-core exposure. There is also a portion of investments in the portfolio about a quarter of that non-core bucket that are equity investments those include equity co-invest as well as LP interest, we've monetized these significant portion of those LP interests over the last quarter. We do have the ability to monetize the balance of those LP interest, but we do…

Operator

Operator

Our next question will come from Fin O'Shea of Wells Fargo. Please go ahead.

Fin O'Shea

Analyst · Wells Fargo. Please go ahead

Appreciate a lot of color given on the portfolio and outlook today. I'll go to portfolio name. Think-5, I believe was a new non-accrual and next kind have been quite a down a bit under your tenure as manager. Can you kind of give us a feel of the -- what's going on underneath there and understanding that it might have just how we looking at the business their customers I believe our major hotel chains? Is there a customer concentration issue there?

Edgar Lee

Analyst · Wells Fargo. Please go ahead

Good morning and thanks for the question. There is a limit to what we can comment on with respect to Think-5 as hopefully you appreciate some of this information is subject to confidentiality arrangements. But what I would say about Thank-5 is, when we first took over the portfolio, we did identify this is one of the non-core underperforming assets in the portfolio. And so we are early on identified that there was an elevated risk associated with this company of defaults and therefore categorized that the way we did. The Company itself has experienced some level of softness, previously had more significant customer concentration. I would say that the Company has done a good job of trying to enhance its overall mix of customers, but it has had some softness over the last few quarters here. Hence, why you’re seeing it reflected and how we’ve marked the position it’s really a function of, it’s not significant disjointedness in the cash flow I would say. I guess I would characterize it more as there’s just generally been softness in that particular situation.

Fin O'Shea

Analyst · Wells Fargo. Please go ahead

Sure. That helps. And then on -- it looks like this quarter you were able to manage a lot of exits on the LP private equity stakes all of course originated under previous management. Can you give us some color on the marks you were able to exit those at, assuming that you found secondary buyers or sold them to an agent of sorts?

Matt Pendo

Analyst · Wells Fargo. Please go ahead

It’s Matt. Thanks for the question. We sold them pretty much, right at our marks. So, it’s a very, very robust market out there for these equities, these positions. So, we’re really pleased with the execution there. And Edgar said, we kept some of the stakes and either some other co- investments we kept. Primarily because we like them and so some of these investments even though there non-core Edgar said, if we see more value in holding them and selling them that’s what we’ll do. So expect to see that over the next few quarters.

Fin O'Shea

Analyst · Wells Fargo. Please go ahead

Okay. That’s all for me. Thanks very much.

Matt Pendo

Analyst · Wells Fargo. Please go ahead

And I do think as relates to kind of the non-core performing. Just I think we, if you look at our deck we posted on Page 7 and 8, I think there’s some good detail that people find helpful in terms of how we provided more information on those to portfolio.

Operator

Operator

The next question will come from Terry Ma of Barclays.

Terry Ma

Analyst · Barclays

So it sounds like from your prepared remarks that you want remain the expense is going forward and you’re just willing to accept the lower yield. So maybe can you just talk broadly about what needs to change for you to be more constructive on the environment and take more risk? Or is this low return environment, just new norm going forward?

Edgar Lee

Analyst · Barclays

I wouldn’t say that lower return environment is the new long-term norm. I think if you look at the history of the credit markets, the ebb and flow and spreads widen and contract. I think the contracting spread environment is just a reflection of increasing competitiveness in the middle market -- the market for middle market loans. We’ve seen a tremendous amount of capital flow into the direct lending space over the last couple of years, and that’s led to aggressiveness among direct lending firms for new assets, and that is led to some spread compression. But also we’ve had a very strong economic environment, and that’s also reflected in credit spreads, which suggest that there is just less risk overall in the marketplace today. Do I think that will correct? It will correct at some point in time. I am not a forecaster of economic activity, but history suggests that we’ll see some level of rebalancing in the credit market at some point in the future. For us, what we’re doing right now is given the breadth of our platform, we’re able to not only look at the private equity or sponsor-backed/owned companies but we’re also able to go and source to look at opportunities in the non-sponsor backed portion in the marketplace, and we’re spending a pretty significant amount of activity in that area of the market because we are just finding less efficiency there and some really interesting opportunities. That doesn’t mean that we are avoiding the private equity marketplace, it just means that we’re exercising a significant amount of discipline there to make sure that we don’t participate in the overall plus portions of that part of the marketplace, as it is today, since taking over management of this BDC, we have increased the non-sponsor portion of the portfolio to approximately 20%, that’s up of about 7% when we initially took over.

Operator

Operator

Next, we have a question from Chris York of JMP Securities.

Chris York

Analyst · JMP Securities

Hey guys just one follow-up. So, as I look line by line at non-accruals or even non-core investments. Is there one investment that you think has the best recovery value in event, let’s say, a couple bulk case events occurred?

Edgar Lee

Analyst · JMP Securities

We’re generally not in the practice of commenting on individual investments. But I would say that general statement, the -- especially in the non-core underperforming portion of the portfolio. I think we have commented in the past and that this portion of the portfolio is marked at an average fair market value of $1.38 and well business conditions -- specific business conditions in the market environment could change and lead to some downside there. We think there is the possibility of also generating some significant an upside there just given where those positions are currently carried today.

Operator

Operator

We have no further questions Mr. Mosticchio.

Michael Mosticchio

Analyst

Thank you again for joining us for our third fiscal quarter 2018 earnings conference call. A replay of this call will be available for 30 days on OCSLs website in the Investor section or by dialing 877-344-7529 for U.S. callers, or 1-412-317-0088 for non-U.S. callers, with a replay access code 101-219-85, beginning approximately one hour after this broadcast.

Operator

Operator

The conference is now concluded. Thank you for attending today’s presentation. You may now disconnect.